What's New:
Recent Quotes:
- $TTFS-TC 174.01 -0.04
- $XFL-ASX 4,725.40 30.40
- $IBC-BSP 9,370.51 -50.16
- $J200-FTSE 24,338.36 0.00
- $XTL-ASX 2,858.20 17.30
November 22, 2009 9:40:06 PM EST
- HUMAN GENOME SCIENCES INC (HGSI)
- Last: 27.38
- Chg: 0.16
- Time: N/A
- Overview
- |
- Charts
- |
- News
- |
- Profile
- |
- Financials
- |
- Holdings
- |
- Insider
- |
- Analysts
- |
- SEC Filings
- |
- Options
- |
- Message Board
HUMAN GENOME SCIENCES INC Headlines
Thursday November 19, 2009
- *Aegera Therapeutics Initiates Randomized Phase 2B Study With AEG35156 For Treatment Of Acute Myeloid Leukemia
09:41:00 EST - *Aegera Therapeutics Announces Dosing Of First Patient In Randomized Phase 2B Study Of AEG35156
09:41:00 EST - Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML)
09:40:00 EST
Wednesday November 18, 2009
Monday November 16, 2009
- Human Genome Sciences Receives Complete Response Letter From FDA For Raxibacumab - Update
09:03:00 EST - Human Genome Receives Complete Response Letter From FDA Relating To Raxibacumab Biologics License Application - Quick Facts
07:18:00 EST - *Human Genome Receives Complete Response Letter From FDA Relating To Raxibacumab Biologics License Application
07:06:00 EST
Stocks Marketplace
- 10 Day Free Demo & Fully Functional Software
- Free Market Forecasts
- Why Do Some Know What To Trade, When? Get LiveCharts Real-Time Quotes, Charts, News.
- What Tools Can Take You To Pro-Level Trading Success? Discover The Answer With eSignal.
- How Do The Pros Make Successful Trades? eSignal Learning's Free Seminars Can Show You.
- How To Profit Using Pivot Points, Candlesticks, And Other Indicators